Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

Synairgen Plc

Sector: Pharmaceutical Preparations Region: United Kingdom


Exchange/Ticker: London Stock Exchange: SNG


Company Description

Synairgen Plc is a drug discovery and development company specializing in respiratory diseases with a focus on asthma and chronic obstructive pulmonary disease. The company focuses on the discovery of new drugs particularly on virus-induced exacerbations of disease which are associated with the majority of healthcare spending for the diseases. Synairgen was founded by Donna E. Davies, Ratko Djukanovic and Stephen T. Holgate in June 2003 and is headquartered in Southampton, the United Kingdom.

Similar to: Sanofi, BioGaia AB, NPS Pharmaceuticals, Inc.

Featured Company


Kindred Healthcare, Inc.

Louisville, KY, US

Kindred Healthcare, Inc., a top-125 private employer in the United States, is a FORTUNE 500 healthcare services company based in Louisville,… Learn more →

You may also be interested in:


NPS Pharmaceuticals, Inc.

Bedminster, NJ, US

NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs… Learn more →

BioGaia AB

Stockholm, SE

BioGaia develops, markets and sells probiotic products with documented health benefits. Its products are primarily based on different… Learn more →

Sanofi

Paris, FR

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’… Learn more →